Nektar Therapeutics (NKTR) EBITDA margin US GAAP (year values)

2020 2021 2022 2022 2023   LTM ?
EBITDA margin, % ? -257.9% -454.3% -353.6% -351.8% -269.8%   -152.6%
Changes by years, y/y, % +76pp -196pp +101pp +2pp +82pp    

Nektar Therapeutics. EBITDA margin, %

Nektar Therapeutics. EBITDA margin, changes, pp

Nektar Therapeutics (NKTR) EBITDA margin US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? -158.6% -140.6% -137.2% -189.2% -142.4%   -152.6%
Changes by years, y/y, % -20pp +31pp +15pp -50pp +16pp    
Changes by quarters, q/q, % -20pp +18pp +3pp -52pp +47pp    

Nektar Therapeutics. EBITDA margin, %

Nektar Therapeutics. EBITDA margin, changes, pp

Nektar Therapeutics. EBITDA margin, changes, pp